These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 27356581)
1. The level of IgG antibodies reactive to TF, Tn and alpha-Gal polyacrylamide-glycoconjugates in breast cancer patients: relation to survival. Smorodin EP; Sergeyev BL Exp Oncol; 2016 Jun; 38(2):117-21. PubMed ID: 27356581 [TBL] [Abstract][Full Text] [Related]
2. The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patients. Smorodin E; Sergeyev B; Klaamas K; Chuzmarov V; Kurtenkov O Int J Med Sci; 2013; 10(12):1674-82. PubMed ID: 24151439 [TBL] [Abstract][Full Text] [Related]
3. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients. Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325 [TBL] [Abstract][Full Text] [Related]
4. IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival. Kurtenkov O; Klaamas K; Rittenhouse-Olson K; Vahter L; Sergejev B; Miljukhina L; Shljapnikova L Exp Oncol; 2005 Jun; 27(2):136-40. PubMed ID: 15995632 [TBL] [Abstract][Full Text] [Related]
5. Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates. Smorodin EP; Kurtenkov OA; Sergeyev BL; Pazynina GV; Bovin NV Glycoconj J; 2004; 20(2):83-9. PubMed ID: 15001840 [TBL] [Abstract][Full Text] [Related]
6. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients. Kodar K; Kurtenkov O; Klaamas K Immunol Invest; 2009; 38(8):704-17. PubMed ID: 19860583 [TBL] [Abstract][Full Text] [Related]
7. The isolation and characterization of human natural alphaGal-specific IgG antibodies applicable to the detection of alphaGal-glycosphingolipids. Smorodin EP; Kurtenkov OA; Shevchuk IN; Tanner RH J Immunoassay Immunochem; 2005; 26(2):145-56. PubMed ID: 15794123 [TBL] [Abstract][Full Text] [Related]
8. The relation of serum anti-(GalNAc beta) and -para-Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer. Smorodin EP; Kurtenkov OA; Sergeyev BL; Chuzmarov VI; Afanasyev VP Exp Oncol; 2007 Mar; 29(1):61-6. PubMed ID: 17431391 [TBL] [Abstract][Full Text] [Related]
9. The level of anti-(GalNAc beta) and anti-para-Forssman disaccharide IgG antibodies in patients with gastrointestinal cancer: relation to survival. Smorodin EP; Kurtenkov OA; Sergeyev BL Exp Oncol; 2013 Jun; 35(2):89-92. PubMed ID: 23828381 [TBL] [Abstract][Full Text] [Related]
10. [ELISA of IgM antibodies to Thomsen-Friedenreich (TF) hapten in cancer diagnostics: comparison of data obtained with four TF-glycoconjugates]. Smorodin EP; Jansson B; Miliukhina L; Paaski G; Bovin NV; Ovchinnikova TV; Kurtenkov O Bioorg Khim; 1997 Oct; 23(10):795-9. PubMed ID: 9490614 [TBL] [Abstract][Full Text] [Related]
11. Specificity of serum anti-A(di) IgG antibodies from patients with gastrointestinal cancer. Smorodin EP; Kurtenkov OA; Sergeyev BL; Branovets JS; Izotova JG; Formanovsky AA J Immunoassay Immunochem; 2011; 32(3):170-90. PubMed ID: 21574090 [TBL] [Abstract][Full Text] [Related]
12. Signatures of anti-Thomsen - Friedenreich antigen antibody diversity in colon cancer patients. Kurtenkov O; Bubina M; Klaamas K Exp Oncol; 2018 Mar; 40(1):48-58. PubMed ID: 29600973 [TBL] [Abstract][Full Text] [Related]
13. Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance. Kurtenkov O; Klaamas K Biomed Res Int; 2017; 2017():6097647. PubMed ID: 28316982 [TBL] [Abstract][Full Text] [Related]
14. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients. Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858 [TBL] [Abstract][Full Text] [Related]
15. The characterization of IgG antibodies to GalNAc beta-terminated glycans of gastric cancer survivors. Smorodin EP; Sergeyev BL; Kurtenkov OA Exp Oncol; 2014 Mar; 36(1):38-43. PubMed ID: 24691283 [TBL] [Abstract][Full Text] [Related]
16. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination. Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349 [TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of thomsen-friedenreich-specific antibodies from human serum. Butschak G; Karsten U Tumour Biol; 2002; 23(3):113-22. PubMed ID: 12218291 [TBL] [Abstract][Full Text] [Related]
18. Anti-Gal IgM, IgA and IgG natural antibodies in childhood. Hamanova M; Chmelikova M; Nentwich I; Thon V; Lokaj J Immunol Lett; 2015 Mar; 164(1):40-3. PubMed ID: 25684746 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers. Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines. Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]